Autologous hematopoietic cell transplantation (HCT) for non-Hodgkin lymphoma (NHL) in patients over 60 years of age

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.20620 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 20620-20620

Author(s):

A. Karampeazis ◽

E. Ayala ◽

W. Poling ◽

L. Balducci ◽

C. Anasetti

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma

Bone Marrow Transplantation ◽

10.1038/s41409-018-0395-y ◽

2018 ◽

Vol 54 (6) ◽

pp. 921-923

Author(s):

Ioanna Sakellari ◽

Eleni Gavriilaki ◽

Stella Bouziana ◽

Varnavas Constantinou ◽

Despina Mallouri ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Conditioning Regimen ◽

Hematopoietic Cell ◽

Effective Alternative ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Late Effects in Survivors of Hodgkin and Non-Hodgkin Lymphoma Treated with Autologous Hematopoietic Cell Transplantation: A Report from the Bone Marrow Transplant Survivor Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.06.003 ◽

2007 ◽

Vol 13 (10) ◽

pp. 1153-1159 ◽

Author(s):

Navneet S. Majhail ◽

Kirsten K. Ness ◽

Linda J. Burns ◽

Can-Lan Sun ◽

Andrea Carter ◽

...

Keyword(s):

Bone Marrow ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Bone Marrow Transplant ◽

Late Effects ◽

Hematopoietic Cell Transplantation ◽

Marrow Transplant ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.09.008 ◽

2008 ◽

Vol 14 (12) ◽

pp. 1323-1333 ◽

Author(s):

Hillard M. Lazarus ◽

Jeanette Carreras ◽

Christian Boudreau ◽

Fausto R. Loberiza ◽

James O. Armitage ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Marrow Transplant ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Long-term outcomes after thiotepa-based high-dose therapy (HDT) and autologous hematopoietic cell transplantation (auto-HCT) in non-Hodgkin lymphoma (NHL)

Bone Marrow Transplantation ◽

10.1038/bmt.2016.275 ◽

2016 ◽

Vol 52 (2) ◽

pp. 321-322 ◽

Author(s):

N Shah ◽

S Rauenzahn ◽

L Veltri ◽

S Wen ◽

M Craig ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

High Dose ◽

Long Term Outcomes ◽

High Dose Therapy ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Leukemia & Lymphoma ◽

10.1080/10428190902756578 ◽

2009 ◽

Vol 50 (3) ◽

pp. 380-386 ◽

Author(s):

Tara Seshadri ◽

Melania Pintilie ◽

John Kuruvilla ◽

Armand Keating ◽

Richard Tsang ◽

...

Keyword(s):

Risk Factors ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Second Cancers ◽

Non Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Hematopoietic cell transplantation for non-Hodgkin lymphoma

The BMT Data Book ◽

10.1017/cbo9781139519205.010 ◽

2013 ◽

pp. 90-112

Author(s):

Saurabh Chhabra ◽

Ginna G. Laport

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma

Download Full-text

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.05.007 ◽

2017 ◽

Vol 99 (1) ◽

pp. 94-102 ◽

Author(s):

Christopher Wilke ◽

Qing Cao ◽

Kathryn E. Dusenbery ◽

Veronika Bachanova ◽

Aleksandr Lazaryan ◽

...

Keyword(s):

Radiation Therapy ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Refractory Hodgkin Lymphoma ◽

Autologous Hematopoietic Cell Transplantation

Download Full-text

Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

Leukemia ◽

10.1038/leu.2014.194 ◽

2014 ◽

Vol 29 (2) ◽

pp. 448-455 ◽

Author(s):

P Satwani ◽

Z Jin ◽

P L Martin ◽

M Bhatia ◽

J H Garvin ◽

...

Keyword(s):

Young Adults ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text

Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma

Leukemia ◽

10.1038/s41375-019-0476-y ◽

2019 ◽

Vol 33 (10) ◽

pp. 2540-2544 ◽

Author(s):

Tania Jain ◽

Craig S. Sauter ◽

Gunjan L. Shah ◽

Molly A. Maloy ◽

Jason Chan ◽

...

Keyword(s):

T Cell ◽

Cell Therapy ◽

B Cell ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Chimeric Antigen Receptor ◽

Hematopoietic Cell Transplantation ◽

Hematopoietic Cell ◽

T Cell Therapy ◽

Non Hodgkin Lymphoma

Download Full-text

Higher Total Body Irradiation (TBI) Dose-Intensity in Fludarabine (Flu)/TBI-Based Reduced-Intensity Conditioning (RIC) Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma (NHL) Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT).

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.12.088 ◽

2020 ◽

Vol 26 (3) ◽

pp. S21-S22

Author(s):

Mehdi Hamadani ◽

Carlos Litovich ◽

Manoj Khanal ◽

Mohamed A. Kharfan-Dabaja ◽

Kwang Woo Ahn

Keyword(s):

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Total Body Irradiation ◽

Hematopoietic Cell Transplantation ◽

Dose Intensity ◽

Hematopoietic Cell ◽

Reduced Intensity Conditioning ◽

Non Hodgkin Lymphoma ◽

Reduced Intensity

Download Full-text